A Structural Equation Model of HIV-related Symptoms, Depressive Symptoms, and Medication Adherence
- PMID: 27695710
- PMCID: PMC5042325
- DOI: 10.16966/2380-5536.123
A Structural Equation Model of HIV-related Symptoms, Depressive Symptoms, and Medication Adherence
Abstract
Adherence to combined antiretroviral therapy (cART) remains critical in management of HIV infection. This study evaluated depression as a potential mechanism by which HIV-related symptoms affect medication adherence and explored if particular clusters of HIV symptoms are susceptible to this mechanism. Baseline data from a multi-visit intervention study were analyzed among 124 persons living with HIV (PLWH). A bifactor model showed two clusters of HIV-related symptom distress: general HIV-related symptoms and gastrointestinal (GI) symptoms. Structural equation modeling showed that both general HIV-related symptoms and GI symptoms were related to higher levels of depressive symptoms, and higher levels of depressive symptoms were related to lower levels of medication adherence. Although general HIV-related symptoms and GI symptoms were not directly related to adherence, they were indirectly associated with adherence via depression. The findings highlight the importance of early recognition and evaluation of symptoms of depression, as well as the underlying physical symptoms that might cause depression, to improve medication adherence.
Keywords: Adherence; Antiretroviral; Depression; Gastrointestinal; HIV; Symptoms.
Figures
Similar articles
-
Association of Depressive Symptoms with Lapses in Antiretroviral Medication Adherence Among People Living with HIV: A Test of an Indirect Pathway.AIDS Behav. 2018 Oct;22(10):3166-3174. doi: 10.1007/s10461-018-2098-1. AIDS Behav. 2018. PMID: 29572762
-
Medication Adherence and HIV Symptom Distress in Relation to Panic Disorder Among HIV-Positive Adults Managing Opioid Dependence.Cognit Ther Res. 2014 Aug;38(4):458-464. doi: 10.1007/s10608-014-9608-x. Cognit Ther Res. 2014. PMID: 26146476 Free PMC article.
-
The Global Landscape of the Burden of Depressive Symptoms/Major Depression in Individuals Living With HIV/AIDs and Its Effect on Antiretroviral Medication Adherence: An Umbrella Review.Front Psychiatry. 2022 May 12;13:814360. doi: 10.3389/fpsyt.2022.814360. eCollection 2022. Front Psychiatry. 2022. PMID: 35633778 Free PMC article.
-
Preliminary Findings on the Association Between Symptoms of Depression and Adherence to Antiretroviral Therapy in Individuals Born Inside Versus Outside of Canada.J Assoc Nurses AIDS Care. 2016 Jul-Aug;27(4):512-23. doi: 10.1016/j.jana.2016.02.005. Epub 2016 Feb 13. J Assoc Nurses AIDS Care. 2016. PMID: 26987784
-
Barriers to HIV Medication Adherence: Examining Distinct Anxiety and Depression Symptoms among Women Living with HIV Who Experienced Childhood Sexual Abuse.Behav Med. 2016;42(2):120-7. doi: 10.1080/08964289.2015.1045823. Behav Med. 2016. PMID: 26010763 Free PMC article.
Cited by
-
The relationship of social support, mental health, and health-related quality of life in human immunodeficiency virus-positive men who have sex with men: From the analysis of canonical correlation and structural equation model: A cross-sectional study.Medicine (Baltimore). 2018 Jul;97(30):e11652. doi: 10.1097/MD.0000000000011652. Medicine (Baltimore). 2018. PMID: 30045316 Free PMC article.
-
Potential Mechanism for HIV-Associated Depression: Upregulation of Serotonin Transporters in SIV-Infected Macaques Detected by 11C-DASB PET.Front Psychiatry. 2019 May 23;10:362. doi: 10.3389/fpsyt.2019.00362. eCollection 2019. Front Psychiatry. 2019. PMID: 31178771 Free PMC article.
-
Chronic SSRI treatment reverses HIV-1 protein-mediated synaptodendritic damage.J Neurovirol. 2021 Jun;27(3):403-421. doi: 10.1007/s13365-021-00960-6. Epub 2021 May 18. J Neurovirol. 2021. PMID: 34003469 Free PMC article.
References
-
- Shuter J, Sarlo JA, Kanmaz TJ, Rode RA, Zingman BS. HIV-infected patients receiving lopinavir/ritonavir-based antiretroviral therapy achieve high rates of virologic suppression despite adherence rates less than 95%. J Acquir Immune Defic Syndr. 2007;45:4–8. - PubMed
-
- Bangsberg DR. Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. Clin Infect Dis. 2006;43:939–941. - PubMed
-
- Gordon LL, Gharibian D, Chong K, Chun H. Comparison of HIV Virologic Failure Rates Between Patients with Variable Adherence to Three Antiretroviral Regimen Types. AIDS Patient Care STDS. 2015;29:384–388. - PubMed
-
- Bangsberg DR, Hecht FM, Charlebois ED, Zolopa AR, Holodniy M, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000;14:357–366. - PubMed
-
- Deeks SG. Treatment of antiretroviral-drug-resistant HIV-1 infection. Lancet. 2003;362:2002–2011. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources